Register to chat with like-minded investors on our interactive forums.

Get Started

ABBV

AbbVie (ABBV)

AbbVie Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 Next >>

Date	Time	Source	Headline	Symbol	Company
05/05/2020	7:01AM	PR Newswire (Canada)	AbbVie reçoit l'approbation de Santé Canada pour l'emploi de VENCLEXTA® (vénétoclax) en association avec l'obinutuzumab ...	NYSE:ABBV	AbbVie Inc
05/05/2020	7:01AM	PR Newswire (Canada)	AbbVie Receives Health Canada Approval for the Combination of VENCLEXTA® (venetoclax) with Obinutuzumab for Patients with Pr...	NYSE:ABBV	AbbVie Inc
05/01/2020	2:58PM	Edgar (US Regulatory)	Notice of Exempt Solicitation. Definitive Material. (px14a6g)	NYSE:ABBV	AbbVie Inc
05/01/2020	10:39AM	Dow Jones News	Form 8.3 - Allergan Plc	NYSE:ABBV	AbbVie Inc
05/01/2020	8:43AM	Dow Jones News	AbbVie Lowers 2020 Earnings Outlook	NYSE:ABBV	AbbVie Inc
05/01/2020	8:29AM	Dow Jones News	AbbVie 1Q Profit, Sales Rise Amid Covid-19-Driven Stock-Up	NYSE:ABBV	AbbVie Inc
05/01/2020	7:45AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ABBV	AbbVie Inc
05/01/2020	7:43AM	PR Newswire (US)	AbbVie Reports First-Quarter 2020 Financial Results	NYSE:ABBV	AbbVie Inc
04/30/2020	10:17AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc
04/29/2020	9:35AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc
04/28/2020	10:02AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc
04/27/2020	12:40PM	Dow Jones News	Harpoon Therapeutics Shares Up 9% on Patient Dosing for Blood Cancer Treatment	NYSE:ABBV	AbbVie Inc
04/27/2020	10:56AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc
04/27/2020	8:14AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ABBV	AbbVie Inc
04/27/2020	8:00AM	PR Newswire (US)	AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes	NYSE:ABBV	AbbVie Inc
04/27/2020	7:10AM	Dow Jones News	Harpoon Therapeutics Doses Patient in Myeloma Trial, Gets $50 Million Milestone Payment	NYSE:ABBV	AbbVie Inc
04/24/2020	5:11PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
04/24/2020	5:09PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
04/24/2020	5:08PM	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NYSE:ABBV	AbbVie Inc
04/24/2020	10:11AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc
04/23/2020	10:06AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc
04/22/2020	10:26AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc
04/21/2020	3:22PM	PR Newswire (US)	IMBRUVICA® (ibrutinib) Receives 11th FDA Approval	NYSE:ABBV	AbbVie Inc
04/21/2020	12:06PM	Dow Jones News	Form 8.3 - [Abbvie Inc]	NYSE:ABBV	AbbVie Inc
04/21/2020	12:00PM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc
04/20/2020	10:48AM	Dow Jones News	Form 8.3 - Allergan Plc	NYSE:ABBV	AbbVie Inc
04/20/2020	8:14AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ABBV	AbbVie Inc
04/20/2020	8:00AM	PR Newswire (US)	AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes	NYSE:ABBV	AbbVie Inc
04/17/2020	11:21AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc
04/16/2020	10:06AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 Next >>

Code Green Apparel (PK)

Movement Industries (PK)

Ethema Health (PK)

Kraig Biocraft Laborator... (QB)

Northwest Biotherapeutics (QB)

Digital Brand Media and ... (PK)

Elite Pharmaceuticals (QB)

Fannie Mae (QB)

Anavex Life Sciences

Brookmount Explorations (PK)

NioCorp Developments

Rennova Health (PK)

RespireRx Pharmaceuticals (PK)

Lightwave Logic

Delayed Upgrade Clock